The University of Louisville’s Cardiothoracic Surgery Residency program is approved by the Accreditation Council for Graduate Medical Education (ACGME) as a two-year clinical program with one resident per year. Residents receive training in adult and pediatric cardiovascular and thoracic surgery.

Requirements

Successful completion of a five-year General Surgery residency program in an ACGME-approved site in the United States.

Foreign candidates must be certified by the Education Commission for Foreign Medical Graduates and have a J1 visa. They must be ABS certified or eligible, and they must be eligible for a Kentucky State Medical License.

The Kentucky Board of Medical Licensure uses the Federation Credentials Verification Service (FCVS). For licensing information please visit the Kentucky Medical Board’s website.

Welcome to the University of Louisville Department of Cardiovascular and Thoracic Surgery, where we strive to provide the highest quality of patient care while training the future leaders in cardiac and thoracic surgery. We offer the latest technologically advanced therapy and device options in the field of thoracic and cardiovascular surgery. I encourage you to browse the information provided on this site to learn more about us what what services we offer.

It is our privilege to serve the patients in the Kentuckiana region by offering an excellent balance of patient centered care, structured education, and a solid, innovative research institute.

Through our practice, our surgeons have pioneered numerous major advancements in cardiothoracic surgery. Our team is dedicated to research; both in the basic science laboratory setting as well as in the clinical environment. It is our goal to expand the treatment options available for our patients and improve clinical outcomes.

Exterior of Cardiovascular Innovation Institute

Our program offers residents the opportunity to participate in research studies at the Cardiovascular Innovation Institute (CII). The CII conducts a multi-disciplinary research and educational program at the interface between biology and engineering. The goal of the program is to address critical clinical problems in cardiovascular disease, to conduct basic research, to transfer advancements to the bedside, and to support the commercialization of discoveries.

Through enhancements in facilities and resources for strategic addition of faculty, staff and students, the CII enables students, faculty and collaborating institutions to make lasting contributions to medicine and biology, to make discoveries, and to develop new technologies.